ArticleJournal of Cancer2025

CCL4 and MIF: Prognostic Biomarkers for Evaluating the Chemoradiotherapy Response and Prognosis in Patients with ESCC.

Yuwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.